title: Glucagon-like peptide-1 analogues for type 2 diabetes.
authors.affiliation: University of Liverpool Diabetes and Endocrinology Clinical Research Unit, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK. j.p.h.wilding@liv.ac.uk
authors.forename: John P H
authors.initials: JP
authors.lastname: Wilding
authors.forename: Kevin
authors.initials: K
authors.lastname: Hardy
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D000077270:Exenatide; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000069450:Liraglutide; D008875:Middle Aged; D010455:Peptides / Q000009:adverse effects / Q000627:therapeutic use*; D014688:Venoms / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide